Global Electronic Health Record Market Set To Grow To $14.7bn By 2022

07 August 2018
Pharma

Visiongain’ has launched a new pharma report Global Electronic Health Record Market 2017-2027: On-premise based EHR, Web-based EHR, Cloud-based EHR, Hospitals, Ambulatory Care Centres, Home Healthcare Agencies, Nursing Homes, Assisted Living Facilities, Diagnostic and Imaging Centres, Pharmacies

Electronic health records are the compilation of medical history and family medical history, which has information about a patient’s lifestyle, physical examination and laboratory results, medications prescribed, and other risk factors. Electronic health record includes the creation, development, design, and maintenance of information systems for the healthcare industry.

The electronic health record market has piqued the interest of healthcare IT companies because of its rising demand. The growth in these solutions is mainly because they offer a very cost effective, convenient, as well as better & enhanced healthcare service. The key players of the world electronic health record market are employing novel concepts and ideas, improving manufacturing techniques, and improving the current set of products, besides enhancing their profitability to gain a competitive edge over other market players.

The lead analyst of the report commented “The market for electronic health record is driven by increasing demand for quality healthcare services and solutions, increasing acceptance of mHealth and telehealth practices, demand for improved patient safety and patient care, and increasing government initiatives to promote electronic health record.

However, safeguarding the confidential information related to patients or healthcare organizations is the biggest challenge for the companies involved in this market, thus data security & privacy concerns are restraining the market growth.”

Leading companies featured in the report include McKesson Corporation, Allscripts Healthcare Solutions, Inc., athenahealth, Inc., Epic Systems Corporation, GE Healthcare, Cerner Corporation, Oracle Corporation, Philips and Infor, Inc.

If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongainglobal.com or call her on +44 (0) 207 336 6100

About visiongain
Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. Based in London, UK, visiongain produces a host of business-to-business reports cusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.

Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.

Recent News

“Global Clinical Trial Supply and Logistics market for pharma set to grow to $26bn by 2024” says new Visiongain report

Emerging markets offer many benefits for companies looking to conduct clinical trials, including large patient population and lower trial costs.

18 April 2019

Read

“Global Biosimilar Drugs market set to grow to $57bn by 2023” says new Visiongain report

The biosimilars landscape will likely to undergo great changes in the future as the market starts to mature.

17 April 2019

Read

“Global Drug Discovery Outsourcing market set to grow to $45bn by 2024” says new Visiongain report

A major restraint in the global drug discovery outsourcing market comes from the fact that it is quickly becoming saturated, with many contract research organisations offering poorly differentiated services.

16 April 2019

Read

“Global Dermatological Drugs market set to grow to $36bn by 2024” says new Visiongain report

The dermatological drugs market has in the past been the domain of small and medium-sized pharma companies specialising in dermatology and perhaps a few other therapeutic areas.

15 April 2019

Read

Kelloggs
3m
Thales
Shell
TEVA
Lockheed-Martin
Pfizer
Raytheon
Halliburton
Du-Pont
Honeywell
Daimler
BASF
Bayer
BP
BAE-Systems
Unilever
WOOCS 2.2.1